The invention of IV Busulfex™ (the intravenous formulation of
busulfan) has contributed to a dramatic change in the standard of care
for patients undergoing stem cell transplantation for leukemia. It
also has greatly improved the outlook for patients with hematologic
(blood) and lymphoid cancers.
In March, the lead
inventor, Borje S. Andersson, M.D., Ph.D., professor in MD Anderson's
Department of Stem Cell Transplantation...
-
MyChart
Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
-
Request an Appointment
If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.
Appointment Information - Donate Today